A Cochrane systematic review of 22 randomized trials involving 1,995 adults with overweight or obesity found intermittent ...

Women and the middle classes are dominating take-up of weight loss injections, research suggests. Analysis of private ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans think about weight loss. In fact, a recent poll finds 1 in 8 adults are now ...

HYDERABAD, Feb 17 (Reuters) - Mounjaro-maker ⁠Eli ⁠Lilly wants to turn India ⁠into a hub for its global supply chain, a senior executive at ​the U.S. drugmaker said, as part of its previously ...

A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label ...

Scientists have discovered a brain signaling pathway that eliminates body fat without reducing food intake by targeting ...

Eli Lilly had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug ahead of an expected decision by the U.S. Food and Drug Administration in April, Reuters writes, ...

Weight loss is common in Parkinson’s disease, but its biological basis has been unclear. Researchers at Fujita Health University show that this loss reflects reduced body fat, not muscle, along with a ...

There are so many reasons to pat yourself on the back after getting in a workout, from building strength to doing your mental ...

A new orally taken, gut-based compound developed by scientists from Nanyang Technological University, Singapore, reduces the amount of dietary fat absorbed in the intestines. This differs from most ...

Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as ...

Octavia Spencer reflects on weight loss, midlife health, and strength alongside Sofia Vergara, in their "Detect the SOS" mission featured in a Super Bowl commercial airing Feb. 8 ...